Cargando…

Magnitude and Variability of the Glucagon-Like Peptide-1 Response in Patients With Type 2 Diabetes up to 2 Years Following Gastric Bypass Surgery

OBJECTIVE: To characterize the magnitude and variance of the change of glucose and glucagon-like peptide-1 (GLP-1) concentrations, and to identify determinants of glucose control up to 2 years after gastric bypass (GBP). RESEARCH DESIGN AND METHODS: Glucose and GLP-1 concentrations were measured dur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van der Schueren, Bart J., Homel, Peter, Alam, Mariam, Agenor, Keesandra, Wang, Gary, Reilly, David, Laferrère, Blandine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241324/ https://www.ncbi.nlm.nih.gov/pubmed/22124715 http://dx.doi.org/10.2337/dc11-1472

Ejemplares similares

Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission
por: Dutia, Roxanne, et al.
Publicado: (2014)

Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass
por: Laferrère, Blandine, et al.
Publicado: (2018)

Response to Comment on Dutia et al. Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission. Diabetes 2014;63:1214−1223
por: Dutia, Roxanne, et al.
Publicado: (2014)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans
por: Salehi, Marzieh, et al.
Publicado: (2011)

Magnitude of slowing gastric emptying by glucagon‐like peptide‐1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes
por: Suganuma, Yumi, et al.
Publicado: (2019)

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass
por: Tharakan, George, et al.
Publicado: (2017)

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Shah, Meera, et al.
Publicado: (2014)

Alteration of the Condylar Oral Bone in Obese and Gastric Bypass Mice
por: Colsoul, Nicolas, et al.
Publicado: (2020)

Chenodeoxycholic acid stimulates glucagon‐like peptide‐1 secretion in patients after Roux‐en‐Y gastric bypass
por: Nielsen, Signe, et al.
Publicado: (2017)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Pre-operative liking and wanting for sweet beverages as predictors of body weight loss after roux-en-Y gastric bypass and sleeve gastrectomy
por: Perez-Leighton, Claudio E., et al.
Publicado: (2019)

Do Roux-en-Y gastric bypass patients meet the dietary guidelines?
por: Gesquiere, Ina, et al.
Publicado: (2014)

Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus
por: Garella, Rachele, et al.
Publicado: (2017)

Glucagon-like peptide-2 protects the gastric mucosa via regulating blood flow and metabolites
por: Zhang, Jing, et al.
Publicado: (2022)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women
por: Montes Castillo, María Cristina, et al.
Publicado: (2019)

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2013)

PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery
por: Ramracheya, Reshma D., et al.
Publicado: (2016)

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
por: Guimarães, Marta, et al.
Publicado: (2015)

Effects of Proximal Gut Bypass on Glucose Tolerance and Insulin Sensitivity in Humans
por: Breitman, Igal, et al.
Publicado: (2013)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study
por: Kuwata, Hitoshi, et al.
Publicado: (2021)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties
por: Marin, Carlos, et al.
Publicado: (2018)

Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration
por: Amato, Antonella, et al.
Publicado: (2019)

Glucagon-like peptide 2 (GLP-2) in bovine colostrum and transition milk
por: Inabu, Yudai, et al.
Publicado: (2021)

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans
por: Nauck, Michael A., et al.
Publicado: (2011)

Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
por: Kobori, Toshiko, et al.
Publicado: (2023)

Glucagon−like Peptide−1 and−2 Levels in Children with Diabetic Ketoacidosis
por: Akıncı, Ayşehan, et al.
Publicado: (2009)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
por: Larsen, Matthias Ploug, et al.
Publicado: (2017)

Conformational Dynamics of Glucagon-like Peptide-2 with Different Electric Field
por: Su, Jingjie, et al.
Publicado: (2022)

Glucagon‐like peptide‐1 therapy for youth with type 2 diabetes
por: Cho, Young Min
Publicado: (2022)

Inter- and intra-individual variability of active glucagon-like peptide 1 among healthy adults
por: Sylvetsky, AC, et al.
Publicado: (2020)

Magnitude and variability of individual elbow load in repetitive baseball pitching
por: van Trigt, Bart, et al.
Publicado: (2023)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_40lkr11e65ap0iduf9cdqoq9fg